Steve Yoo

Steve Yoo serves as the Chief Financial Officer at MedGene Therapeutics, Inc. since 2022. Prior to this role, Steve was a General Partner at PhiFund from 2021 to 2022 and held the position of Senior Analyst at Sofinnova from 2017 to 2020. Earlier experience includes positions as an Analyst at Surveyor Capital (2014-2016) and US FP&A Aranesp at Amgen (2013-2014). Steve also worked as Vice President at Leerink Swann (2008-2012), Associate Analyst at UBS (2007-2008), and Research Associate at Sanford C. Bernstein from October 2005 to March 2007, specializing in the Biotech team. Steve holds a Bachelor of Science degree in Biology from the Massachusetts Institute of Technology.